Graig Suvannavejh: ASCO is one of the highlights of our year in biotech

Graig Suvannavejh, Managing Director of Equity Research at Mizuho Securities, discusses major ASCO presentations, biotech volatility, cancer breakthroughs and emerging oncology companies to watch.